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Nod2 is an intracellular sensor linked to Crohn’s disease, an inflammatorymalady of the intestinal tract. In this
issue of Immunity, Kim et al. (2011) demonstrate that Nod2 is responsible for regulating monocyte-attracting
chemokines to the inflamed gut.It has been over a decade since germline
polymorphisms in NOD2 (then called
CARD15) were uncovered in a subset of
familial Crohn’s disease (CD) cases. This
finding has been confirmed in multiple
genome-wide association studies of vast
numbers of CD patients and engendered
a search for the underlying mechanisms
that link loss-of-function alleles of Nod2
to excessive inflammation in the intestinal
tract (Strober et al., 2007; Franke et al.,
2010). In this issue of Immunity, Kim
et al. show that in an acute pathogenic
intestinal infection model, Nod2 is essen-
tial for mediating the production of the
chemokine CCL2 to signal to the bone
marrow to increase the recruitment of
inflammatory monocytes that home to
the gut and restore intestinal homeostasis
(Kim et al., 2011). The results of Kim et al.
(2011) suggest that the functions of Nod2
in inflammatory homeostasis involve
communication between the stressed
gut and the bone marrow, where large
numbers of immune cells need to be
made and sent to the gut to resolve
the infection. Understanding the Nod2-
CCL2 connection is thus likely to point to
new aspects of the underlying defects
in CD.
Nod2 is an intracellular molecule of the
nucleotide-binding domain and leucine-
rich repeat containing (NLR) class that
comprises at least 20 members in
mammals and many more in lower inver-
tebrates such as sea urchins. Worms
and insects do not have NLR proteins,
but plants have dozens of different types
that are coevolving with specific patho-
gens (Chen et al., 2009). Nod2, like many
other NLR proteins, is considered to be
a key intracellular detector of pathogens,
akin to the Toll-like receptor (TLR) family
expressed on the cell surface or endo-cytic compartments. Indeed, Nod2 has
been shown to have an irreplaceable
function in the recognition of the muramyl
dipeptide (MDP) moiety of bacterial
peptidoglycan (Strober et al., 2006). In
the last ten years, at least five different
mouse models of Nod2 loss-of-function,
and potentially gain-of-function, mutants
have been created, and extensive efforts
have been made to tie Nod2 to the patho-
genic intestinal inflammation that defines
CD. In particular, the recognition events
that lead from MDP to activation of
NF-kB signaling and other downstream
signaling events have been intensively
investigated.
A popular model of Nod2 function
posits that it acts as a receptor for bacte-
rial MDP (either derived from intracellular
bacteria or actively transported into the
cell) and the recognition event leads to
downstream signaling via the adapater
kinase Rip2 and subsequent activation
of immune responses; the Nod2-MDP
signaling pathway would therefore be
defective in CD by an unresolved mecha-
nism, since CD is associated with exces-
sive intestinal immune responses that
are not easily reconciled with defects
in Nod2-dependent bacterial detection
(Strober et al., 2006). The paradigm of
the Nod2-MDP link has, however, been
recently chiseled away by a diverse set
of findings. First, no study has ever directly
shown that Nod2 binds MDP. From
genetic studies in mice and in macro-
phages that lackNod2 there is noquestion
that Nod2 is a required step in MDP
detection and response, but whether
this interaction is direct or indirect remains
in dispute. Furthermore, there is an
absence of convincing biochemical or
structural data to show direct interactions
between any mammalian NLR and itsImmunityproposed pathogen-derived ligand(s).
Second, Nod2 plays decisive roles in the
immune responses to double-stranded
RNA viruses, the T cell response to the
protozoan parasite Toxoplasma gondii,
and responses to oil adjuvants: in none
of these cases is MDP or bacteria obvi-
ously involved, arguing that Nod2 has
more general effects in immune regulation
(Moreira et al., 2008; Sabbah et al., 2009;
Shaw et al., 2009). Third, and most impor-
tant for the study of Kim et al. (2011), Nod2
cannot discriminate between MDP made
by commensal bacteria or pathogenic
bacterial invaders in the gut, since MDP
is MDP and present in all bacterial pepti-
doglycan. Collectively, these data argue
that we need to expand our view of
Nod2, and NLR function in general,
beyond direct bacterial recognition to
consider the possibility that NLR proteins
such as Nod2 potentially have a multitude
of functions.
Kim et al. (2011) used amousemodel of
aggressive gram-negative intestinal infec-
tion caused by Citrobacter rodentium.
The Citrobacter model is widely accepted
as a reasonable model of acute intestinal
infections caused by pathogenic E. coli
variants. This model is likely to be
important for understanding human CD,
as recent studies have shown that certain
adherent-invasive E. coli strains are
elevated in number in CD, and these
strains have an increased ability to
attach to Nod2-deficient Peyer’s patches,
possibly promoting intestinal invasion
(Chassaing et al., 2011). Oral Citrobacter
inoculation causes a predictable infection
characterized by bacterial proliferation,
epithelial damage, and a rapid resolution
phase that restores the integrity of the
epithelium. By contrast, Citrobacter-
infected Nod2-deficient mice showed34, May 27, 2011 ª2011 Elsevier Inc. 693
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Figure 1. Nod2 Regulates Gut-Bone Marrow Communication via CCL2
In a normal mouse, Citrobacter infection elicits CCL2 production from the colonic epithelium in a Nod2-dependent way. The CCL2 drives monocyte egress from
the bone marrow and recruitment to the ongoing infection in the gut. There, monocytes contribute to the resolution of the infection in multiple ways including
promoting the protective Th1 cell response and anti-Citrobacter IgG production. In the absence of Nod2, CCL2 is not produced in sufficient amounts, delaying
bacteria clearance and causing increased inflammation. How Nod2 in colonic epithelia senses the presence of Citrobacter relative to the endogenous flora
remains a mystery.
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a greatly increased bacterial load in the
gut compared to control mice. Nod2-defi-
cient mice eventually cleared the infec-
tion, but at a cost, since the inflammatory
insult in the gut was prolonged. On first
glance these data are surprising because
MDP from commensal bacteria would be
present in the gut regardless of whether
Citrobacter was growing or not. There-
fore, Nod2 seems to have a function in
detecting the presence of pathogenic
bacteria or tissue stress by a mechanism
unlikely to involve direct MDP recognition.
Following the finding of the essential role
of Nod2 in establishing a productive
inflammatory response in the gut, Kim
et al. (2011) then employed an elegant
step-wise approach to deciphering the
underlying mechanisms involved in the
Nod2 defect (Figure 1). First they showed
that Nod2 was needed to make adequate
amounts of the chemokine CCL2. CCL2
entices inflammatory monocytes to sites
of infection and tissue damage. In Citro-
bacter infection, nonhematopoietic cells,
especially the intestinal stroma, made
CCL2 in a Nod2-dependent way, support-
ing previous data showing that Nod2 has
marked effects in regulating intestinal
epithelial cell homeostasis (Cruickshank
et al., 2008). Thus, Kim et al. (2011) were
also able to tie specific defects in mono-694 Immunity 34, May 27, 2011 ª2011 Elsevicyte recruitment to the gut that were
dependent on the CCL2 receptor CCR2:
adoptive transfer of monocytes into
Ccr2/ mice was sufficient to restore
clearance of Citrobacter, regardless of
whether the Ly6Chi monocytes were
derived from wild-type or Nod2/ mice.
These data also emphasize that the large
endogenous mononuclear phagocyte
population of the intestine is insufficient
to manage an acute infection and needs
reinforcement from freshly produced
monocytes.
The link between T helper 1 (Th1) cell-
mediated immunity in the gut has long
fascinated immunologists, especially as
Th1 cell responses are closely tied to
the pathogenesis of CD (Strober et al.,
2007). In the case of Citrobacter infection,
Nod2-deficient mice had a delay in the
production of gut Th1 cells that are
required for resolution of the infection (in
part via the induction of anti-Citrobacter
IgG). However, the Th1 cell response
was eventually mounted in the absence
of Nod2, and Kim et al. (2011) argue
that this restoration is because of com-
pensatory mechanisms. Indeed, Nod2
synergizes with TLR signaling, both nega-
tively and positively (Strober et al., 2006).
The interplay between NLR and TLR
signaling is of great importance, because
in normal mammals both pathways woulder Inc.be anticipated to work together to estab-
lish and modulate immunity. The Nod2-
TLR interaction is also likely to be a
component of the underlying pathology
in CD, although the synergy, or lack of
synergy, between the pathways remains
contentious as far as human IBD is
concerned.
The results of Kim et al. (2011) highlight
the need for more sophisticated tools to
dissect Nod2 function (and indeed all
NLR proteins) in gut immune responses.
In particular, a conditional inducible dele-
tion of Nod2 during different phases of
acute and chronic inflammation would
be especially useful, since the current
models use conventional Nod2-deficient
mice thatmay have developed amultitude
of adaptations to compensate for the loss
of Nod2. Thus, infection with Citrobacter,
or indeed any colitis-inducing insult fol-
lowed by inducible deletion of Nod2 at
different times, may be a more valuable
way to dissect the complexities of intes-
tinal immunity.REFERENCES
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Familial Mediterranean fever is caused bymutations of the PYRIN protein. Chae et al. (2011) provide evidence
for a ASC protein-dependent pathway of caspase-1 activation in which gain-of-function PYRIN mutations
lead to IL-1b cytokine overproduction and inflammatory disease.Autoinflammatory syndromes are rare
disorders characterized by recurrent epi-
sodes of systemic inflammation and fever
in the absence of microbial infection or
autoimmunity. Accumulating evidence
indicate that these diseases are caused
by abnormal activation of the innate im-
mune system with little or no involvement
of T and B cells. Familial Mediterranean
fever (FMF), a disease that is prevalent
among Eastern Mediterranean popula-
tions, is the most frequent autoinflamma-
tory disorder and is caused by inherited
mutations in the MEFV gene, which
encodes a 781 amino acid protein known
as PYRIN (Kastner et al., 2010). Human
PYRIN consists of an N-terminal Pyrin
domain (PYD) linked to two central
B-box zinc-finger and coiled-coil domains
and a C-terminal B30.2 domain (also
called SPRY). To date, more than 50
FMF-associated PYRIN mutations have
been identified, most of which are clus-
tered within the B30.2 domain, which is
surprisingly absent in mouse Pyrin. FMF
has been traditionally considered a re-
cessive disorder in that in most patients,
both PYRIN alleles aremutated. However,
there is also evidence that disease can
occur in some patients harboring a
single mutated PYRIN allele (Kastner
et al., 2010). Furthermore, up to 20% ofFMF patients lack identifiable PYRIN
mutations.
Although thecasual linkbetweenPYRIN
mutations and FMF is well established,
there is controversy about the physiolog-
ical role of PYRIN and how PYRIN muta-
tions promote disease. Initial experiments
with mice expressing a truncated form of
mouse PYRIN suggested that PYRIN
functions as a negative regulator of cas-
pase-1 activation (Chae et al., 2003).
PYRIN was suggested to compete with
caspase-1 for binding toASC, aPYD-con-
taining adaptor protein that links nucleo-
tide-binding domain and leucine-rich
repeat containing proteins (NLRs) to
pro-caspase-1 in several inflammasome
pathways (Franchi et al., 2009). The main
function of caspase-1 is to induce the
maturation and secretion of the proinflam-
matory cytokines IL-1b and IL-18. Mice
expressing only the PYD domain were
more susceptible to stimulation with lipo-
polysaccharide (LPS), and macrophages
stimulated with LPS produced more
IL-1b. These data are consistent with a
model in which full-length PYRIN, but not
its truncated version consisting of only
the PYD domain, acts as a negative regu-
lator of caspase-1. In linewith an inhibitory
role, PYRIN was found to associate with
inflammasome components includingNLRP3, ASC, and caspase-1, which
can disrupt the interaction between cas-
pase-1 and ASC and lead to reduced
caspase-1 activation (Chae et al., 2006;
Dowds et al., 2003; Papin et al., 2007).
However, the resultswithmice expressing
a truncated PYRIN are open to an alterna-
tive interpretation. PYRIN may promote
the activation of caspase-1 by interacting
with ASC, but this is normally blocked in
the full-length protein where PYRIN is
kept in an inactive conformation. Consis-
tent with this second possibility, some
studies showed that PYRIN promotes
ASC dimerization and caspase-1 activa-
tion (Seshadri et al., 2007; Yu et al., 2006).
In linewith a positive role for PYRIN,proline
serine threonine phosphatase-interacting
protein 1 (PSTPIP1), a protein that is
mutated in PAPA syndrome, another
FMF-related autoinflammatory disorder,
binds to and activates PYRIN, which pro-
motes ASC dimerization and caspase-1
activation (Yu et al., 2007). Notably,
PAPA-associated PSTPIP1 mutants ex-
hibited an enhanced ability to induce
PYRINactivation (Yuetal., 2007). The latter
work suggests that PSTPIP1 and PYRIN
are components of a molecular pathway
that leads to caspase-1 activation.
In this issue of Immunity, Chae et al.
(2011) report the development of a mouse34, May 27, 2011 ª2011 Elsevier Inc. 695
